Skip to main content
Equibles

Michael A. Panzara

Immunic, Inc. (IMUX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael A. Panzara

Immunic, Inc. reported in an 8-K filed August 11, 2026 that Michael A. Panzara was appointed Chief Medical Officer, effective April 24, 2026. Immunic, Inc. reported in an 8-K filed April 28, 2026 that Michael A. Panzara was appointed Chief Medical Officer, effective April 24, 2026.

“Appointment of Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, effective April 24, 2026.”
Immunic, Inc. Form 8-K, filed August 11, 2026 · Read the filing
“today announced the appointment of Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, effective April 24, 2026.”
Immunic, Inc. Form 8-K, filed April 28, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Immunic, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.